4-(6-anilino-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(1-benzylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(6-bromo-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-[1-(4-fluorophenyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;4-[1-(2,2,2-trifluoroethyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;dihydrochloride

C65H54BrCl2F4N31O5 — CID 173219598

IUPAC4-(6-anilino-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(1-benzylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(6-bromo-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-[1-(4-fluorophenyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;4-[1-(2,2,2-trifluoroethyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;dihydrochloride
SMILESCCn1c(-c2nonc2N)nc2cnc(Br)cc21.CCn1c(-c2nonc2N)nc2cnc(Nc3ccccc3)cc21.Cl.Cl.Nc1nonc1-c1nc2cnccc2n1-c1ccc(F)cc1.Nc1nonc1-c1nc2cnccc2n1CC(F)(F)F.Nc1nonc1-c1nc2cnccc2n1Cc1ccccc1
InChIInChI=1S/C16H15N7O.C15H12N6O.C14H9FN6O.C10H9BrN6O.C10H7F3N6O.2ClH/c1-2-23-12-8-13(19-10-6-4-3-5-7-10)18-9-11(12)20-16(23)14-15(17)22-24-21-14;16-14-13(19-22-20-14)15-18-11-8-17-7-6-12(11)21(15)9-10-4-2-1-3-5-10;15-8-1-3-9(4-2-8)21-11-5-6-17-7-10(11)18-14(21)12-13(16)20-22-19-12;1-2-17-6-3-7(11)13-4-5(6)14-10(17)8-9(12)16-18-15-8;11-10(12,13)4-19-6-1-2-15-3-5(6)16-9(19)7-8(14)18-20-17-7;;/h3-9H,2H2,1H3,(H2,17,22)(H,18,19);1-8H,9H2,(H2,16,20);1-7H,(H2,16,20);3-4H,2H2,1H3,(H2,12,16);1-3H,4H2,(H2,14,18);2*1H
InChIKeyKEUVKTUTNOPQTF-UHFFFAOYSA-N
MW1576.16 g/mol
LogP11.45
Rot. Bonds13

About 4-(6-anilino-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(1-benzylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(6-bromo-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-[1-(4-fluorophenyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;4-[1-(2,2,2-trifluoroethyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;dihydrochloride

4-(6-anilino-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(1-benzylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(6-bromo-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-[1-(4-fluorophenyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;4-[1-(2,2,2-trifluoroethyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;dihydrochloride (PubChem CID 173219598) has the molecular formula C65H54BrCl2F4N31O5 and a molecular weight of 1576.16 g/mol. Its IUPAC name is 4-(6-anilino-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(1-benzylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(6-bromo-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-[1-(4-fluorophenyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;4-[1-(2,2,2-trifluoroethyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;dihydrochloride.

Molecular Properties

Compound Name4-(6-anilino-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(1-benzylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(6-bromo-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-[1-(4-fluorophenyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;4-[1-(2,2,2-trifluoroethyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;dihydrochloride
PubChem CID173219598
Molecular FormulaC65H54BrCl2F4N31O5
Molecular Weight1576.16 g/mol
Exact Mass1573.34
IUPAC Name4-(6-anilino-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(1-benzylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(6-bromo-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-[1-(4-fluorophenyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;4-[1-(2,2,2-trifluoroethyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;dihydrochloride
SMILESCCn1c(-c2nonc2N)nc2cnc(Br)cc21.CCn1c(-c2nonc2N)nc2cnc(Nc3ccccc3)cc21.Cl.Cl.Nc1nonc1-c1nc2cnccc2n1-c1ccc(F)cc1.Nc1nonc1-c1nc2cnccc2n1CC(F)(F)F.Nc1nonc1-c1nc2cnccc2n1Cc1ccccc1
InChIInChI=1S/C16H15N7O.C15H12N6O.C14H9FN6O.C10H9BrN6O.C10H7F3N6O.2ClH/c1-2-23-12-8-13(19-10-6-4-3-5-7-10)18-9-11(12)20-16(23)14-15(17)22-24-21-14;16-14-13(19-22-20-14)15-18-11-8-17-7-6-12(11)21(15)9-10-4-2-1-3-5-10;15-8-1-3-9(4-2-8)21-11-5-6-17-7-10(11)18-14(21)12-13(16)20-22-19-12;1-2-17-6-3-7(11)13-4-5(6)14-10(17)8-9(12)16-18-15-8;11-10(12,13)4-19-6-1-2-15-3-5(6)16-9(19)7-8(14)18-20-17-7;;/h3-9H,2H2,1H3,(H2,17,22)(H,18,19);1-8H,9H2,(H2,16,20);1-7H,(H2,16,20);3-4H,2H2,1H3,(H2,12,16);1-3H,4H2,(H2,14,18);2*1H
InChIKeyKEUVKTUTNOPQTF-UHFFFAOYSA-N
XLogP11.45
TPSA490.28 Ų
H-Bond Donors6
H-Bond Acceptors36
Rotatable Bonds13
Heavy Atoms108
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001576.16
LogP ≤ 511.45
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1036

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Analyze 4-(6-anilino-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(1-benzylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(6-bromo-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-[1-(4-fluorophenyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;4-[1-(2,2,2-trifluoroethyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;dihydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-(6-anilino-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(1-benzylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(6-bromo-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-[1-(4-fluorophenyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;4-[1-(2,2,2-trifluoroethyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;dihydrochloride?
The IUPAC name of 4-(6-anilino-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(1-benzylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(6-bromo-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-[1-(4-fluorophenyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;4-[1-(2,2,2-trifluoroethyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;dihydrochloride (CID 173219598) is 4-(6-anilino-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(1-benzylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(6-bromo-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-[1-(4-fluorophenyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;4-[1-(2,2,2-trifluoroethyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;dihydrochloride.
What is the SMILES notation for 4-(6-anilino-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(1-benzylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(6-bromo-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-[1-(4-fluorophenyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;4-[1-(2,2,2-trifluoroethyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;dihydrochloride?
The canonical SMILES for 4-(6-anilino-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(1-benzylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(6-bromo-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-[1-(4-fluorophenyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;4-[1-(2,2,2-trifluoroethyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;dihydrochloride is CCn1c(-c2nonc2N)nc2cnc(Br)cc21.CCn1c(-c2nonc2N)nc2cnc(Nc3ccccc3)cc21.Cl.Cl.Nc1nonc1-c1nc2cnccc2n1-c1ccc(F)cc1.Nc1nonc1-c1nc2cnccc2n1CC(F)(F)F.Nc1nonc1-c1nc2cnccc2n1Cc1ccccc1.
What is the InChIKey of 4-(6-anilino-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(1-benzylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(6-bromo-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-[1-(4-fluorophenyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;4-[1-(2,2,2-trifluoroethyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;dihydrochloride?
The InChIKey is KEUVKTUTNOPQTF-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H15N7O.C15H12N6O.C14H9FN6O.C10H9BrN6O.C10H7F3N6O.2ClH/c1-2-23-12-8-13(19-10-6-4-3-5-7-10)18-9-11(12)20-16(23)14-15(17)22-24-21-14;16-14-13(19-22-20-14)15-18-11-8-17-7-6-12(11)21(15)9-10-4-2-1-3-5-10;15-8-1-3-9(4-2-8)21-11-5-6-17-7-10(11)18-14(21)12-13(16)20-22-19-12;1-2-17-6-3-7(11)13-4-5(6)14-10(17)8-9(12)16-18-15-8;11-10(12,13)4-19-6-1-2-15-3-5(6)16-9(19)7-8(14)18-20-17-7;;/h3-9H,2H2,1H3,(H2,17,22)(H,18,19);1-8H,9H2,(H2,16,20);1-7H,(H2,16,20);3-4H,2H2,1H3,(H2,12,16);1-3H,4H2,(H2,14,18);2*1H.
What are the key properties of 4-(6-anilino-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(1-benzylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(6-bromo-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-[1-(4-fluorophenyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;4-[1-(2,2,2-trifluoroethyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;dihydrochloride?
4-(6-anilino-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(1-benzylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(6-bromo-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-[1-(4-fluorophenyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;4-[1-(2,2,2-trifluoroethyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;dihydrochloride has a molecular weight of 1576.16 g/mol, XLogP of 11.45, 13 rotatable bonds, 6 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(6-anilino-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(1-benzylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-(6-bromo-1-ethylimidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine;4-[1-(4-fluorophenyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;4-[1-(2,2,2-trifluoroethyl)imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;dihydrochloride is sourced from PubChem (CID 173219598), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).